World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
18858
World Ranking
2733
National Ranking
25

Overview

Jinlin Hou is a researcher affiliated with Southern Medical University in China, specializing in medicine with a significant focus on hepatology and related fields. Their body of work spans several interconnected areas including epidemiology, infectious diseases, molecular biology, and immunology.

Their research primarily revolves around key topics such as Hepatitis B Virus Studies, Hepatitis C virus research, and liver disease diagnosis and treatment. Additional focus areas comprise hepatocellular carcinoma treatment and prognosis, hepatitis viruses studies and epidemiology, cancer genomics and diagnostics, and liver disease and transplantation.

Among notable recent papers authored by or associated with scientists in their circle are:

  • "Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China," 2020, published in Nature Medicine
  • "Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)," 2023, published in Liver Cancer
  • "aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis," 2020, published in Journal of Hepatology
  • "Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection," 2022, published in New England Journal of Medicine
  • "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)," 2023, published in Journal of Clinical and Translational Hepatology

Jinlin Hou frequently collaborates with several researchers in their field, including:

  • Jian Sun
  • Rong Fan
  • Xieer Liang
  • Bin Zhou
  • Junqi Niu

Their publications are commonly found in specific scientific venues known for hepatology and clinical research, such as:

  • Journal of Hepatology
  • Journal of Clinical and Translational Hepatology
  • Alimentary Pharmacology & Therapeutics
  • PubMed
  • Journal of Medical Virology

Jinlin Hou's expertise in epidemiology underpins much of their research on infectious diseases related to liver health. With a strong emphasis on clinical applications and guidelines, their work contributes to understanding liver cancer, hepatitis infections, and treatment outcomes.

Best Publications

  • Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

    S. K. Sarin;M. Kumar;G. K. Lau;Z. Abbas

  • Epidemiology and Prevention of Hepatitis B Virus Infection.

    Jinlin Hou;Zhihua Liu;Fan Gu

  • Hepatocellular carcinoma in the Asia Pacific region.

    Man-Fung Yuen;Jin-Lin Hou;Anuchit Chutaputti

  • Therapeutic strategies for hepatitis B virus infection: towards a cure

    Gregory C Fanning;Fabien Zoulim;Jinlin Hou;Antonio Bertoletti

  • Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

    Graham S Cooke;Isabelle Andrieux-Meyer;Tanya L Applegate;Rifat Atun

  • Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.

    Xin Xu;Jian Sun;Sheng Nie;Huiyuan Li

  • Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound.

    Jie Wang;Tao Shen;Xiangbo Huang;G. Renuka Kumar

  • Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)

    Qin Ning;Meifang Han;Yongtao Sun;Jiaji Jiang

  • aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.

    Rong Fan;George Papatheodoridis;Jian Sun;Hamish Innes

  • [The guideline of prevention and treatment for chronic hepatitis B: a 2015 update].

    Jin-Lin Hou;Wei lai

  • Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B

    Stefan Zeuzem;Edward Gane;Yun Fan Liaw;Seng G. Lim

  • Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update).

    Jinlin Hou;Guiqiang Wang;Fusheng Wang;Jun Cheng

  • Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.

    George Ka-Kit K. Lau;Manuel Tsiang;Jinlin Hou;Siu-Tsan Yuen

  • Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial†‡

    Jinlin Hou;You-Kuan Yin;Daozhen Xu;Deming Tan

  • Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.

    Zhanhui Wang;Jin Zhang;Hong Yang;Xiuhui Li

  • Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents.

    Cheng Wang;Dong Ji;Jing Chen;Qing Shao

  • Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats.

    Yue Hy;Yin C;Hou Jl;Zeng X

  • qFibrosis: A fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients

    Shuoyu Xu;Yan Wang;Yan Wang;Dean C.S. Tai;Shi Wang

  • Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection.

    Zhihua Liu;Jinlin Hou

  • Prevention of hepatocellular carcinoma in the Asia-Pacific region: Consensus statements

    GC Farrell;HL Chan;Rmf Yuen;DN Amarapurkar

  • A new intertype recombinant between genotypes C and D of hepatitis B virus identified in China.

    Zhanhui Wang;Zhihua Liu;Guobing Zeng;Shujuan Wen

Frequent Co-Authors

Hui Zhuang
Hui Zhuang Peking University
Zhihua Liu
Zhihua Liu Peking Union Medical College Hospital
Nikolai V. Naoumov
Nikolai V. Naoumov Novartis (Switzerland)
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam
Henry Lik-Yuen Chan
Henry Lik-Yuen Chan Chinese University of Hong Kong
Zhihong Liu
Zhihong Liu Nanjing University
Jun Cheng
Jun Cheng University of Chinese Academy of Sciences
Mengji Lu
Mengji Lu University of Duisburg-Essen
Bettina E. Hansen
Bettina E. Hansen University Health Network
Hao Wang
Hao Wang Swinburne University of Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring immunology, understanding related healthcare degrees can open diverse career pathways. Many professionals interested in patient care or research often consider online nursing programs for non nurses, which offer a flexible way to enter the nursing field without prior nursing experience.

Accelerated BSN programs for non nurses are another popular option for those looking to fast-track their nursing education. These programs typically build on previous academic achievements, allowing students to complete their Bachelor of Science in Nursing in a shorter timeframe compared to traditional routes.

For individuals seeking quicker entry into the healthcare workforce, easy admission LPN programs provide accessible routes to becoming licensed practical nurses. These programs focus on foundational nursing skills and are designed to be approachable for students from various backgrounds.

Additionally, what is the easiest NP program is a common query for those aiming to become nurse practitioners with advanced clinical roles. These programs often balance rigorous training with streamlined admission processes to accommodate working professionals.

Exploring these related degrees offers flexible and practical options that complement immunology expertise, expanding career prospects in healthcare and biomedical sciences.

Best Scientists Citing Jinlin Hou

Trending Scientists

Recently Published Articles